Fine Chemicals Division logo

Drug Conjugate

During the last decade, Johnson Matthey has developed strong expertise and proficiency in polymer drug conjugate (PDC) chemistry. Our expert scientists effectively plan and execute the process development and scale-up for linking small molecule payloads to polymers in support of PDCs, antibody drug conjugates (ADCs) and other drug delivery applications. You can trust Johnson Matthey as your partner for development and production services throughout the life cycle of your PDC.

We have the expertise and ability for:

  • Modification and conjugation of diverse types of polymers including PEGs, polyamides, polyesters, polysaccharides, and polypeptides
  • Derivatisation of polymers with multiple APIs
  • Controlled molecular weight distribution
  • Handling highly potent, cytotoxic compounds
  • Taking your compound from development through to commercialisation.